AAAAAA
Results: 1-25/49
Authors:
EXTERMANN M
BALDUCCI L
LYMAN G
Citation: M. Extermann et al., WHAT THRESHOLD FOR ADJUVANT TAMOXIFEN IN OLDER BREAST-CANCER PATIENTS- A DECISION-ANALYSIS, European journal of cancer, 34, 1998, pp. 103-103
Authors:
BALDUCCI L
Citation: L. Balducci, GEMCITABINE - A REASONABLE CHOICE FOR FRAIL PATIENTS WITH CANCER, Annals of oncology, 9, 1998, pp. 8-8
Authors:
BALDUCCI L
Citation: L. Balducci, THE APPLICATION OF THE PRINCIPLES OF GERIATRICS TO THE MANAGEMENT OF OLDER PERSONS WITH CANCER, Annals of oncology, 9, 1998, pp. 9-9
Authors:
OVERCASH J
CHEN H
EXTERMANN M
CANTOR A
BALDUCCI L
Citation: J. Overcash et al., UNDERSTANDING THE COMPREHENSIVE-GERIATRIC-ASSESSMENT (CGA) IMPACT ON SURVIVAL AND TIME TO DISEASE PROGRESSION IN OLDER CANCER-PATIENTS, Annals of oncology, 9, 1998, pp. 45-45
Authors:
EXTERMANN M
BALDUCCI L
LYMAN GH
Citation: M. Extermann et al., WHAT THRESHOLD FOR ADJUVANT THERAPY IN OLDER BREAST-CANCER PATIENTS, Annals of oncology, 9, 1998, pp. 96-96
Authors:
ZACHARIAH B
BALDUCCI L
PATEL S
PATIL J
ZACHARIAH AB
GREENBERG HM
MOFFITT HL
Citation: B. Zachariah et al., RADIOTHERAPY FOR PROSTATE-CANCER IN THE OLDER PATIENTS, Annals of oncology, 9, 1998, pp. 148-148
Authors:
BROECKEL JA
JACOBSEN PB
HORTON J
BALDUCCI L
LYMAN GH
Citation: Ja. Broeckel et al., CHARACTERISTICS AND CORRELATES OF FATIGUE AFTER ADJUVANT CHEMOTHERAPYFOR BREAST-CANCER, Journal of clinical oncology, 16(5), 1998, pp. 1689-1696
Authors:
EXTERMANN M
OVERCASH J
LYMAN GH
PARR J
BALDUCCI L
Citation: M. Extermann et al., COMORBIDITY AND FUNCTIONAL STATUS ARE INDEPENDENT IN OLDER CANCER-PATIENTS, Journal of clinical oncology, 16(4), 1998, pp. 1582-1587
Authors:
GARBASSI F
BALDUCCI L
UNGARELLI R
Citation: F. Garbassi et al., SOL-GEL PREPARATION AND CHARACTERIZATION OF SPHERICAL ZRO2-SIO2 PARTICLES, Journal of non-crystalline solids, 223(3), 1998, pp. 190-199
Authors:
BALDUCCI L
ALBERGO G
CIUFFREDA M
SAMPALMIERI F
Citation: L. Balducci et al., POLYMERIZATION TYPES AND FLUORIDE RELEASE FROM 2 GLASS IONOMERIC CEMENTS, Journal of dental research, 77, 1998, pp. 1229-1229
Authors:
BALDUCCI L
PHILLIPS DM
Citation: L. Balducci et Dm. Phillips, BREAST-CANCER IN OLDER WOMEN, American family physician, 58(5), 1998, pp. 1163-1172
Authors:
KIMMICK GG
FLEMING R
MUSS HB
BALDUCCI L
Citation: Gg. Kimmick et al., CANCER-CHEMOTHERAPY IN OLDER ADULTS - A TOLERABILITY PERSPECTIVE, Drugs & aging, 10(1), 1997, pp. 34-49
Authors:
BALDUCCI L
Citation: L. Balducci, HIGHLIGHTS OF THE 3RD INTERNATIONAL-CONFERENCE IN GERIATRIC ONCOLOGY HELD IN TAMPA, FLORIDA, 13-15 NOVEMBER 1996, European journal of cancer, 33(6), 1997, pp. 836-837
Authors:
BALDUCCI L
EXTERMANN M
FENTIMAN I
MONFARDINI S
PERRONE F
Citation: L. Balducci et al., SHOULD ADJUVANT CHEMOTHERAPY BE USED TO TREAT BREAST-CANCER IN ELDERLY PATIENTS (GREATER-THAN-OR-EQUAL-TO-70 YEARS OF AGE), European journal of cancer, 33(11), 1997, pp. 1720-1722
Authors:
BALDUCCI L
Citation: L. Balducci, CANCER IN THE ELDERLY .2. PREFACE, Clinics in geriatric medicine, 13(2), 1997, pp. 13-14
Authors:
BALDUCCI L
POWSANG J
FRIEDLAND J
DIAZ JI
Citation: L. Balducci et al., PROSTATE-CANCER, Clinics in geriatric medicine, 13(2), 1997, pp. 283
Authors:
BALDUCCI L
LYMAN GH
Citation: L. Balducci et Gh. Lyman, CANCER IN THE ELDERLY - EPIDEMIOLOGIC AND CLINICAL IMPLICATIONS, Clinics in geriatric medicine, 13(1), 1997, pp. 1
Authors:
BALDUCCI L
Citation: L. Balducci, CANCER IN THE ELDERLY .1. PREFACE, Clinics in geriatric medicine, 13(1), 1997, pp. 13-15
Authors:
BALDUCCI L
TROTTI A
Citation: L. Balducci et A. Trotti, ORGAN PRESERVATION - AN EFFECTIVE AND SAFE FORM OF CANCER-TREATMENT, Clinics in geriatric medicine, 13(1), 1997, pp. 185
Authors:
ZACHARIAH B
BALDUCCI L
VENKATTARAMANABALAJI GV
CASEY L
GREENBERG HM
DELREGATO JA
Citation: B. Zachariah et al., RADIOTHERAPY FOR CANCER-PATIENTS AGED 80 AND OLDER - A STUDY OF EFFECTIVENESS AND SIDE-EFFECTS, International journal of radiation oncology, biology, physics, 39(5), 1997, pp. 1125-1129
Authors:
BALDUCCI L
EXTERMANN M
Citation: L. Balducci et M. Extermann, CANCER-CHEMOTHERAPY IN THE OLDER PATIENT - WHAT THE MEDICAL ONCOLOGIST NEEDS TO KNOW, Cancer, 80(7), 1997, pp. 1317-1322
Authors:
SABA HI
ATANES I
MORELLI GA
BALDUCCI L
AGOSTI S
SABA SR
Citation: Hi. Saba et al., PREKALLIKREIN (PK, FLETCHER FACTOR) DEFICIENCY IN A PATIENT WITH METASTATIC RENAL-CELL CARCINOMA, Blood, 90(10), 1997, pp. 3193-3193
Authors:
BENSON K
LYMAN G
AGOSTI S
BALDUCCI L
POWSANG J
SABA H
Citation: K. Benson et al., ESTIMATED BLOOD-LOSS IN GROUP-O AS COMPARED TO NON-GROUP-O RADICAL PROSTATECTOMY PATIENTS, Blood, 90(10), 1997, pp. 3281-3281
Authors:
PATTERSON SG
BENSON K
BALDUCCI L
EXTERMANN M
LYMAN GH
LEE H
Citation: Sg. Patterson et al., COST REDUCTIVE USE OF ERYTHROPOIETIN IN PATIENTS WITH MYELODYSPLASIA, Blood, 90(10), 1997, pp. 3324-3324
Authors:
BALDUCCI L
IOVINO R
Citation: L. Balducci et R. Iovino, THE AMERICAN-PHYSICIANS-POETRY-ASSOCIATION, Journal of the American Geriatrics Society, 45(1), 1997, pp. 122-122